Screener
Denali Therapeutics Inc. DNLI Business Segments — Interest and other income, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
| Line item | Therapeutics Segment / Three Months Ended June 30, 2026 | Therapeutics Segment / Three Months Ended June 30, 2025 | Therapeutics Segment / Six Months Ended June 30, 2026 | Therapeutics Segment / Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Personnel related selling, general and administrative expenses | 22,921 | 20,115 | 45,485 | 38,853 |
| Other selling, general and administrative expenses | 13,362 | 12,152 | 24,309 | 22,767 |
| Total selling, general and administrative expenses | 36,283 | 32,267 | 69,794 | 61,620 |
| Intangible asset amortization | $750 | — | $750 | — |
| Segment operating expenses | 134,145 | 134,963 | 271,502 | 280,543 |
| Segment loss from operations | (130,541) | (134,963) | (267,898) | (280,543) |
| Segment interest and other income, net | 2,988 | 10,844 | 11,898 | 23,454 |
| Segment net loss | $(127,553) | $(124,119) | $(256,000) | $(257,089) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Denali Therapeutics Inc.'s business segments — interest and other income, net?
- Denali Therapeutics Inc. (DNLI) reported business segments — interest and other income, net of $2.99M in Q2 2026.
- How has Denali Therapeutics Inc.'s business segments — interest and other income, net changed year-over-year?
- Denali Therapeutics Inc.'s business segments — interest and other income, net decreased by 72.4% year-over-year, from $10.84M to $2.99M.
- What is the long-term trend for Denali Therapeutics Inc.'s business segments — interest and other income, net?
- Over 3 years (2022 to 2025), Denali Therapeutics Inc.'s business segments — interest and other income, net has grown at a 42.7% compound annual growth rate (CAGR), from $14.77M to $42.9M.
- What does business segments — interest and other income, net mean?
- Includes interest earned on cash and investment balances, as well as other non-operating gains or losses. This metric reflects the company's ability to generate returns on its capital reserves or other non-core activities. It provides a secondary source of liquidity that can help offset operational losses.
Ask your AI about Denali Therapeutics Inc.'s business segments — interest and other income, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude